Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > Why words are meaningless

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Feb 04, 2024 9:34am

66 Views

Post# 35861785

RE:Why words are meaningless

Ciao, "Most of us understand that it's results that matter..."

Results driven, Gilles has brought the pipeline right up to the goal line. He is literaly leading the world:

"I look forward to completing the development of technologies such as PGX, that continue to demonstrate its ability to successfully generate novel bioactive delivery systems at a quality that no other known technologies have been able to generate." Michel Regnier, Senior Vice President, Technical Operations

The merger fully finances CZO's near-term reveue generating opportunities. A man of results, Ronnie Miller, who is arguably the most important executive in Canada of the last 20 years is "thrilled". Ronnie has Gilles by his side and Gilles is in the catbird seat of both companies. They also have results driven industry leaders Natex, Dr. Hoare, Dr. Kolb, Dr. Li, Dr. Tardif, and Bloom Burton by their side. The Canadian government has provided significant and on-going funding after its due diligence. The merger arguably values CZO's shares with a target price of $1.25 given H.C. Wainwright's target for AEZS and that it is a merger of equals. The stock should move towards this with events.

The path,
the daisy chain of events that will define this merger...

AEZS's diagnostic test clinical trial results for children
Launch of powder formulations of CZO's two active ingredients(beta glucan, avenanthramide)
CZO's main client returns
AEZS's diagnostic continuing roll-out for adults
FDA approval for the test for children
Licensing deal for the diagnostic test for North America
Commissioning of 5X PGX scale-up
Commissioning of 10X scale-up to decision point for mass industrialization of PGX
PGX licensing deal
Immune booster plant
Phase I avenanthramide clinical trial results
Wound healing results
Wound healing partnership
Fibrosis clinical trial 'go'/'no go' decision and regulatory filing
Phase IIa avenanthramide clinical trial results
Avenanthramide pill partnership
AIM Biologicals 'go'/'no go' clinical trial decision

Image result for daisy chain fireworks